What sectors does MVM Life Science Partners invest in?

Global healthcare VC. $700M+ across 4 funds. Invests in biopharma, medtech, and digital health from seed to late stage. Aggregate $20-100M per company over holding period.

Typical check size

€15M – €30M

Fund size: $700M+ across 4 funds (MVM IV: $233M)

Browse similar check sizes →

Portfolio highlights

Domantis - antibody engineering (acquired by GSK)

Heptares Therapeutics - GPCR drugs (acquired by Sosei $400M)

Cara Therapeutics - pain therapeutics

Momenta - biotech drug discovery

Contact

mvm.com

United Kingdom

Research with AI

Learn more about MVM Life Science Partners using AI:

Ask ChatGPT Ask Perplexity

Pitch guides

Learn what MVM Life Science Partners and similar investors look for:

AI pitch guide Biotech pitch guide Healthtech pitch guide

More investors in United Kingdom

20VC 2150 6 Degrees Capital 83North View all in United Kingdom

Related resources

Seed fundraising guide Seed pitch deck guide Series A fundraising guide Series A pitch deck guide Series B fundraising guide Growth fundraising guide

Fundraising in United Kingdom

Tips, programs, and cultural notes

More AI investors

1750 Ventures 20VC 212 360 Capital View all AI investors

Venture capital

United Kingdom

MVM Life Science Partners

Investment focus

Sectors

Biotech

Healthtech

Investment stages

Geographic focus

United States

United Kingdom

Europe

Investment thesis

Global healthcare VC. $700M+ across 4 funds. Invests in biopharma, medtech, and digital health from seed to late stage. Aggregate $20-100M per company over holding period.